Regeneron Pharmaceuticals
A Precision Medicine Strategy Lead (Senior Scientist) at Regeneron is part of the Precision Medicine group focused on clinical translational science and biomarker strategy for therapeutic candidates across Immunology, Ophthalmology, and Infectious Disease. The role centers on integrating translational approaches into clinical development and partnering with discovery and internal laboratories to advance biomarker-informed decision making.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Laboratory Assistant II, Analytical and Biological Mass Spectrometry (ABMS)
Regeneron Pharmaceuticals
Biomarker and Precision Medicine Lead
Sanofi
Biomarker and Precision Medicine Lead
Sanofi
Biomarker and Precision Medicine Lead
Sanofi
Associate Director / Principal Research Scientist II, Precision Medicine Immunology
AbbVie
Clinical Director (Principal Scientist), Translational Medicine, Immunology
MSD
Head of Translational & Precision Medicine
USAJOBS